Esperion Therapeutics Inc (NASDAQ: ESPR) is -28.18% lower on its value in year-to-date trading and has touched a low of $1.47 and a high of $3.94 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ESPR stock was last observed hovering at around $1.54 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $1.58, the stock is -4.76% and -15.76% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.46 million and changing 2.60% at the moment leaves the stock -25.95% off its SMA200. ESPR registered -22.93% loss for a year compared to 6-month loss of -17.28%. The firm has a 50-day simple moving average (SMA 50) of $1.8756 and a 200-day simple moving average (SMA200) of $2.1336.
The stock witnessed a -15.05% gain in the last 1 month and extending the period to 3 months gives it a -38.04%, and is 1.94% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.55% over the week and 6.99% over the month.
Esperion Therapeutics Inc (ESPR) has around 304 employees, a market worth around $312.60M and $332.31M in sales. Profit margin for the company is -15.57%. Distance from 52-week low is 7.48% and -59.90% from its 52-week high. The company has generated returns on investments over the last 12 months (-53.02%).
with sales reaching $54.97M over the same period.The EPS is expected to grow by 83.04% this year, but quarterly earnings will post 4.87% year-over-year. Quarterly sales are estimated to shrink -60.09% in year-over-year returns.
Esperion Therapeutics Inc (ESPR) Top Institutional Holders
226.0 institutions hold shares in Esperion Therapeutics Inc (ESPR), with institutional investors hold 65.95% of the company’s shares. The shares outstanding are 197.85M, and float is at 195.89M with Short Float at 14.88%. Institutions hold 65.72% of the Float.
The top institutional shareholder in the company is WASATCH ADVISORS LP with over 16.86 million shares valued at $37.44 million. The investor’s holdings represent 8.9319% of the ESPR Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 13.98 million shares valued at $31.04 million to account for 8.2617 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 10.82 million shares representing 6.3907% and valued at over $24.01 million, while BELLEVUE GROUP AG holds 5.2672 of the shares totaling 9.94 million with a market value of $22.08 million.
Esperion Therapeutics Inc (ESPR) Insider Activity
#####
Still, SEC filings show that on Mar 18 ’25, Koenig Sheldon L. (Officer) Proposed Sale 13,047 shares at an average price of $1.50 for $19619.0. The insider now directly holds shares of Esperion Therapeutics Inc (ESPR).
